VitsGen Therapeutics Inc.
1 clinical trials · Sponsor
◉ Watch VitsGen Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Clinical Evaluation of 177Lu-PSMA-VG01 Injection in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer （mCRPC） (NCT07660211) | VitsGen Therapeutics Inc. | 2026-06-16 |
Track VitsGen Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.